Loading clinical trials...
Loading clinical trials...
Single Arm Evaluation of Romiplostim to Prevent Chemotherapy Induced Thrombocytopenia in Patients With Ewing Sarcoma
Conditions
Interventions
Romiplostim (AMG-531)
Locations
2
United States
Phoenix Children's
Phoenix, Arizona, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Start Date
January 26, 2024
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2028
Last Updated
March 18, 2026
NCT02390843
NCT00165139
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions